Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
Financial Statements-2022
Parent Company Only Financial Statement-2022
Consolidated Financial Statements
-2022
Prev
PREVIOUS
The Board of Directors approved 2022 consolidated financial statements.
NEXT
The Company is invited to attend an institutional investor conference hosted by President Securities on April 27, 2023.
Next
Investors
Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
